Steven Cohen’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Buy
512,506
+387,272
+309% +$1.13M ﹤0.01% 2659
2026
Q2
$406K Buy
125,234
+8,239
+7% +$24.1K ﹤0.01% 3269
2026
Q1
$289K Sell
116,995
-616,488
-84% -$1.3M ﹤0.01% 3380
2025
Q4
$1.5M Buy
+733,483
New +$2.12M ﹤0.01% 2651
2024
Q4
– Sell
-107,360
Closed -$366K – 2159
2024
Q3
$366K Buy
+107,360
New +$467K ﹤0.01% 1676
2024
Q1
– Sell
-579,967
Closed -$5.88M – 2294
2023
Q4
$5.88M Buy
579,967
+577,767
+26,262% +$5.07M 0.01% 866
2023
Q3
$17.2K Sell
2,200
-879
-29% -$7.54K ﹤0.01% 2301
2023
Q2
$25.3K Sell
3,079
-224,721
-99% -$1.96M ﹤0.01% 1744
2023
Q1
$1.65M Buy
+227,800
New +$2.03M 0.01% 1015
2019
Q1
– Sell
-58,745
Closed -$1.34M – 1071
2018
Q4
$1.34M Sell
58,745
-38,655
-40% -$1.05M 0.01% 774
2018
Q3
$3.1M Buy
+97,400
New +$3.15M 0.01% 686

Other funds holding EDIT

Steven Cohen's EDIT Position: Q3 2026 in Review

Steven Cohen increased its Editas Medicine (EDIT) stake by 309% in Q3 2026, buying an estimated $1.13M and bringing the position to 512,506 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

Steven Cohen first reported a position in EDIT in Q3 2018 and has held it in 11 quarters since. The position peaked at $5.88M in Q4 2023. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Steven Cohen held 512,506 shares of Editas Medicine worth $1.32M as of Q3 2026.
  • Steven Cohen bought 387,272 Editas Medicine shares in Q3 2026, an estimated $1.13M.
  • Editas Medicine made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2659 holding.
  • Steven Cohen first reported a position in Editas Medicine in Q3 2018 and has held it in 11 quarters since.
  • Steven Cohen's Editas Medicine position peaked at $5.88M in Q4 2023.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.